Aged people are the most susceptible group to COVID-19 infection. Immunosenescence
characterized by impairment of immune function with inflamm-aging contributes to …

The recent impact of SARS‐CoV‐2 and coronavirus disease 2019 (COVID‐19) has shown
major differences in infrastructure and approach across healthcare systems worldwide. One …

The SARS-CoV-2 enters the human airways and comes into contact with the mucous
membranes lining the mouth, nose, and eyes. The virus enters the healthy cells and uses …

COVID-19 has proliferated ageism. The impetus of this article is to show that
immunosenescence is a risk factor to COVID-19 and not aging per se. Based on the idea …

Abstract Coronavirus disease 2019 (COVID-19) can be a critical disease, particularly in the
elderly and those with comorbidities. Patients with Alzheimer's disease are more vulnerable …

Objectives There is growing evidence of neurological involvement of SARS-CoV-2 in some
otoneurological subjective symptoms such as balance disorders. The aim of this work was to …

Abstract The World Health Organization designated the decade 2020–2030 as the “decade
of healthy ageing.” It is a tragic irony that the year 2020 should begin with a pandemic that is …

Worldwide excess mortality (EM) data have the potential to provide a better estimation of the
impact of the pandemic. This study aims to investigate and map the inequalities in EM in …

Age is a key risk factor associated with the severity of symptoms caused by SARS-CoV-2,
and there is an urgent need to reduce COVID-19 morbidity and mortality in elderly …

This study examined the difference in expenditure behavior by age group through an
empirical analysis of changes in card expenditure after the COVID-19 outbreak, using card …